Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XEL vs GSK✓SelectedUSD · GSKXEL vs GSK performance historyLatest closeAs of-0.20%11/20
Stock and ETF performance explorer

XEL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.1%
GSK return
+53.4%
Excess return
-7.3%
Maximum drawdown
-24.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.2%-0.1%-0.1%-0.2%
7D-2.8%-5.3%+2.5%-1.9%
30D+3.3%-3.7%+6.9%+3.9%
3M+1.6%-7.3%+8.8%+2.9%
6M+0.9%-4.2%+5.1%+1.5%
YTD+9.9%+0.9%+9.0%+9.1%
1Y+2.9%+7.3%-4.4%+1.1%
3Y+46.1%+52.7%-6.7%+22.8%
All+46.1%+53.4%-7.3%+22.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling